Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for ...

The Company reiterated its outlook for the full year ending December 31, 2025, with revenue expected to be in the range of approximately $2.06 billion to $2.11 billion, and adjusted EBITDA expected to ...

Evonik has completed the transition of its global PU-additive production sites to green electricity, aligning with its sustainability goals of re ...

Evonik Coating Additives has introduced four new AERODISP® dispersions, designed to enhance waterborne inkjet ink receptive coatings by improvin ...